
    
      The study will comprise a screening visit, followed by CABG and/or valve surgery on Day 1,
      double-blind treatment period and a follow-up period up to Day 90 in subjects with
      moderate/severe risk of AKI (acute kidney injury) at 2-22 hours post-surgery.

      Subjects with low risk of AKI at 2-22 hours post-surgery assessment will be enrolled in the
      observational cohort to evaluate subject characteristics and biomarkers for exploratory
      objectives.
    
  